Skip to content

MRI Flow Offset Correction Study

In-vivo validation of background offset correction in MRI phase contrast velocity acquisitions

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20847
Enrollment
120
Registered
2014-09-19
Start date
2014-07-28
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood flow measurement with MRI in the large vessel around the heart (aorta and pulmonary artery) show a measurement error

Interventions

Observational study. Seperate phantom measurements will be obtained after an in vivo clinical MRI scan.

Sponsors

VU University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Informed consent - Sinus rhythm at CMR examination - 2D flow acquisitions by MRI at the aorta or pulmonary artery without spatial infolding artefacts. - MRI acquisition on MRI system by Siemens: Magnetom Avanto, VB17 or newer 1.5 T systems such; for GE: Signa Excite (HDx 15M4) or newer as the Optima MR360; and for Philips: Achieva R2.6.3 or newer as the Ingenia. - MRI flow acquisitions with the general accepted standard settings

Exclusion criteria

Exclusion criteria: - Incapacitated adults. - Lack of a phantom measurement within the protocol specifications.

Design outcomes

Primary

MeasureTime frame
The primary study outcome parameter is the velocity offset in cm/s at the location of the aorta or pulmonary artery.

Secondary

MeasureTime frame
- To describe the offset error over the systems included in the study - To test whether the static phantom offset corrections are valid, the difference between the velocity at the thorax wall and the phantom be assessed. - The validity of offset corrections using higher order fitting, and the LPC filter.

Contacts

Public ContactM.B.M. Hofman

dept. Physics & Medical Technology VU University Medical Center P.O. Box 7057, 1007 MB Amsterdam, the Netherlands

mbm.hofman@vumc.nl+31-20-4444 593

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)